Dakota Wealth Management Sells 17,691 Shares of McKesson Corporation $MCK

Dakota Wealth Management cut its position in McKesson Corporation (NYSE:MCK) by 95.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 757 shares of the company’s stock after selling 17,691 shares during the period. Dakota Wealth Management’s holdings in McKesson were worth $585,000 at the end of the most recent reporting period.

Other hedge funds have also recently added to or reduced their stakes in the company. Brighton Jones LLC lifted its holdings in shares of McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company’s stock worth $1,438,000 after purchasing an additional 798 shares in the last quarter. Caxton Associates LLP acquired a new stake in shares of McKesson in the 1st quarter worth about $233,000. Sivia Capital Partners LLC lifted its holdings in shares of McKesson by 77.9% in the second quarter. Sivia Capital Partners LLC now owns 685 shares of the company’s stock valued at $502,000 after purchasing an additional 300 shares in the last quarter. Howard Capital Management Inc. lifted its stake in McKesson by 11.4% during the 2nd quarter. Howard Capital Management Inc. now owns 858 shares of the company’s stock valued at $629,000 after acquiring an additional 88 shares in the last quarter. Finally, World Investment Advisors boosted its holdings in McKesson by 7.8% during the second quarter. World Investment Advisors now owns 6,313 shares of the company’s stock worth $4,626,000 after purchasing an additional 456 shares during the last quarter. Institutional investors and hedge funds own 85.07% of the company’s stock.

Trending Headlines about McKesson

Here are the key news stories impacting McKesson this week:

• Positive Sentiment: Quarterly results showed revenue and operating profit ahead of expectations and management set FY‑2026 EPS guidance (38.80–39.20), reinforcing upward revisions to earnings expectations and investor confidence. A Look At McKesson (MCK) Valuation After Strong Earnings And Growing Analyst Optimism
• Positive Sentiment: Barclays raised its price target to $1,050 (from $960) and kept an Overweight rating, signaling continued analyst support that can attract additional fund buying. Barclays Boosts McKesson (MCK) Price Target, Says Shares Likely to Stay in Favor
• Positive Sentiment: Large institutional inflows have been a key technical driver this year; “big money” accumulation is cited as a reason for the stock’s strong multi‑month run and elevated relative performance. See How Institutional Inflows Make McKesson Fly
• Positive Sentiment: Shares reached an all‑time high, reinforcing momentum and likely triggering additional momentum/quant buying and headline attention. McKesson stock hits all-time high at 972.06 USD
• Neutral Sentiment: Coverage consensus is constructive (e.g., a “Moderate Buy” consensus from brokerages), but valuation metrics (P/E ~28, strong YTD gains) are noted — suggesting upside is supported but the stock could be sensitive to any guidance hiccups or macro shocks. McKesson Corporation (NYSE:MCK) Receives Consensus Rating of “Moderate Buy” from Brokerages

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on MCK. JPMorgan Chase & Co. upped their price objective on McKesson from $983.00 to $1,107.00 and gave the company an “overweight” rating in a research note on Tuesday, February 10th. UBS Group raised their price target on McKesson from $920.00 to $980.00 and gave the stock a “buy” rating in a report on Thursday, November 6th. Robert W. Baird set a $968.00 target price on shares of McKesson in a report on Wednesday, January 14th. Zacks Research lowered McKesson from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, November 25th. Finally, Weiss Ratings cut shares of McKesson from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Thursday, February 5th. Thirteen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $943.50.

Insider Activity

In other McKesson news, Director Maria Martinez sold 349 shares of the stock in a transaction on Thursday, February 19th. The stock was sold at an average price of $939.87, for a total transaction of $328,014.63. Following the sale, the director directly owned 301 shares in the company, valued at approximately $282,900.87. This trade represents a 53.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of the business’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 1,143 shares of company stock worth $1,046,070. Corporate insiders own 0.08% of the company’s stock.

McKesson Trading Up 1.1%

Shares of McKesson stock opened at $973.59 on Friday. The company’s fifty day simple moving average is $865.48 and its two-hundred day simple moving average is $803.36. The company has a market cap of $119.26 billion, a P/E ratio of 28.00, a PEG ratio of 1.55 and a beta of 0.40. McKesson Corporation has a 12-month low of $619.48 and a 12-month high of $977.27.

McKesson (NYSE:MCK) last released its earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The firm had revenue of $106.16 billion for the quarter, compared to the consensus estimate of $105.98 billion. During the same period in the prior year, the firm earned $8.03 EPS. The company’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. Analysts predict that McKesson Corporation will post 32.77 EPS for the current fiscal year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 1st. Stockholders of record on Monday, March 2nd will be paid a $0.82 dividend. This represents a $3.28 annualized dividend and a dividend yield of 0.3%. The ex-dividend date is Monday, March 2nd. McKesson’s dividend payout ratio is currently 9.43%.

McKesson Profile

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.